entecavir / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
entecavir / Generic mfg.
NCT03489239: Entecavir to TAF Switch

Active, not recruiting
3
27
US
Tenofovir Alafenamide, TAF
Thomas Jefferson University, Gilead Sciences
Hepatitis B
08/20
09/20
NCT05115942: Hydronidone for the Treatment of Liver Fibrosis Associated With Chronic Viral Hepatitis B Phase 3 Trial.

Recruiting
3
248
RoW
Hydronidone capsules, F351, The placebo capsules, N
Beijing Continent Pharmaceutical Co, Ltd.
Liver Fibrosis
03/24
06/24

Download Options